Butterfly Network Enters the Bladder Scanning Market With First Specialty Product, iQ+ Bladder, in the United States
Butterfly Network has launched its first specialty product, iQ+ Bladder, aimed at the bladder scanning market in the United States.
This product expands Butterfly's reach beyond its core point-of-care ultrasound market, leveraging its proprietary Ultrasound-on-Chip™ technology. The bundled solution includes an iQ+ Bladder probe, streamlined software, a compact rolling cart, a tablet, and a power splitter.
The iQ+ Bladder enables nurses to obtain automated bladder volume calculations with 3D visualizations swiftly. The user-friendly interface, robust design, and advanced visualization capabilities make it a valuable tool in today's healthcare environment, targeting efficiency, reliability, and workflow optimization. The product is designed to meet the needs of nurses and other providers who conduct regular bladder scans.
- Expansion into the bladder scanning market diversifies Butterfly's product offerings and potential revenue streams.
- Utilization of proprietary Ultrasound-on-Chip™ technology reinforces Butterfly's commitment to innovation.
- The iQ+ Bladder product includes a probe, streamlined software, and supportive hardware, optimizing user convenience and efficiency.
- Automated bladder volume calculations with 3D visualizations can improve diagnostic accuracy and speed.
- User-friendly interface and no login or configuration requirements promote ease of use.
- Durable construction and advanced visualization capabilities enhance the reliability and effectiveness of the product.
- Potential market acceptance risk as the product is newly launched and requires adoption by healthcare providers.
- Initial costs associated with the bundled solution may be prohibitive for some smaller healthcare facilities.
- Competition in the bladder scanning market could impact Butterfly's market share and profitability.
Insights
The announcement of Butterfly Network's iQ+ Bladder marks a significant diversification from its core market. By extending its technology into the bladder scanning market, Butterfly is positioning itself to capture a broader segment of the healthcare technology space. This move could be seen as a strategic effort to leverage its existing Ultrasound-on-Chip™ technology, thus capitalizing on new revenue streams.
Market Segmentation: The bladder scanning market has been underserved with affordable and user-friendly solutions, indicating a potential high demand for Butterfly's new product. From an ROI perspective, the product's features—such as 3D visualization, streamlined software and robust hardware—could be attractive to healthcare providers seeking efficient, cost-effective solutions.
Competitive Landscape: The company faces competition from established players in the medical device sector, which could impact market penetration. However, its unique selling points offer a compelling argument for adoption, especially in cost-sensitive markets.
Butterfly Network's iQ+ Bladder is positioned as a more accessible bladder scanning solution, potentially disrupting an area that has seen limited innovation. The use of proprietary Ultrasound-on-Chip™ technology provides a compact and efficient alternative to traditional bladder scanners. This could lead to more widespread adoption among healthcare facilities where space and budget constraints are significant concerns.
Technological Advancements: The 3D visualization and automated bladder volume calculation can significantly reduce human error, improving diagnostic accuracy. The user-friendly interface and lack of required configurations contribute to ease of use, which is important in fast-paced medical environments. The durable construction ensures the device can withstand daily use, enhancing its long-term value proposition.
From a financial standpoint, Butterfly Network's entry into the bladder scanning market could signal a new growth phase. The company is leveraging its core technology into a new application, potentially opening up new revenue streams. This diversification could mitigate risks associated with reliance on a single market segment.
Revenue Potential: The affordability and user-friendliness of the iQ+ Bladder could drive high adoption rates, particularly in smaller healthcare facilities or those with budget constraints. This could result in substantial sales volume over time, contributing positively to Butterfly Network's revenue.
Investment Implications: While the initial reception of the iQ+ Bladder will be critical, its long-term success will depend on sustained demand and the company's ability to outmaneuver competitors. Investors should watch for sales performance data and customer feedback in the coming quarters.
- With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology.
- The bundled bladder solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly.
Butterfly iQ+ Bladder includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly. (Photo: Business Wire)
“The launch of the Butterfly iQ+ Bladder demonstrates Butterfly’s commitment to extending our powerful Ultrasound-on-Chip™ technology into more markets where innovation is needed,” said Joseph DeVivo, President, Chief Executive Officer, and Chairman of Butterfly Network. “With iQ+ Bladder, we move outside of our core point-of-care ultrasound market to better address the bladder scanning market, which has long awaited a more affordable, user-friendly solution. We listened to the unique needs of our nursing and bladder scanning customers and brought them a purpose-built, streamlined solution that meets their fast pace and high workload.”
The iQ+ Bladder probe is powered by Butterfly’s proprietary Ultrasound-on-Chip™ technology and features durable construction that is built for daily use. The rolling cart features storage space and a probe charging dock for enhanced convenience and readiness, and a large tablet is mounted to the cart with tilted brackets that rotate 360° and pan 180° for optimum viewing and positioning.
The probe is paired with streamlined software, designed to address the specific needs of nurses and other providers who regularly conduct bladder scans. The application has a user-friendly interface, with no login or configurations necessary, allowing for immediate access to quick and intuitive scans. To empower confident, accurate measurement, the solution offers walkthrough guidance for proper probe placement, and also leverages Butterfly’s advanced bladder visualization capabilities, including 3D rendering to confirm true bladder anatomy.
“In today’s healthcare environment, nurses need a plug and play solution that allows them to confidently boot up and quickly get an accurate bladder volume measurement, and department directors are looking for more affordable, reliable solutions that drive value back to the organization,” said John Martin, MD, Chief Medical Officer of Butterfly Network. “These are the challenges we set out to tackle with our new iQ+ Bladder solution, which we’ve centered around efficiency, ease, reliability and workflow optimization.”
For more information about Butterfly Network and the Butterfly iQ+ Bladder, please visit www.butterflynetwork.com/bladder-scanner, or reach out to your Butterfly Sales Representative for a demo or quote. The company will also offer a probe-only purchase option.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515835233/en/
Butterfly Media:
Liz Learned
Head of Corporate Communications, Butterfly
media@butterflynetwork.com
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officer, Butterfly
investors@butterflynetwork.com
or
Neal Nagarajan
IR Agency Representative
Sloane & Company
(301) 273-5662
nnagarajan@sloanepr.com
Source: Butterfly Network, Inc.
FAQ
What is the new product launched by Butterfly Network?
What technology does the Butterfly iQ+ Bladder use?
What features are included in the iQ+ Bladder solution?
How does the iQ+ Bladder benefit nurses?
Where is the iQ+ Bladder product available?
